Your browser doesn't support javascript.
loading
Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line.
Aktas, Yesim; Celik Tekeli, Merve; Celebi, Nevin.
Afiliação
  • Aktas Y; Department of Pharmaceutical Technology, Erciyes University Faculty of Pharmacy, Kayseri, Turkey.
  • Celik Tekeli M; Department of Pharmaceutical Technology, Erciyes University Faculty of Pharmacy, Kayseri, Turkey.
  • Celebi N; Department of Pharmaceutical Technology, Gazi University Faculty of Pharmacy, Ankara, Turkey.
J Microencapsul ; 37(1): 41-51, 2020 Jan.
Article em En | MEDLINE | ID: mdl-31714163
ABSTRACT

Aim:

Aim of this study was to develop exendin-4 and exendin-4/chymostatin loaded self-nanoemulsifying drug delivery system (SNEDDS).

Methods:

Surfactants and co-surfactants were mixed, oil phase containing exendin-4 or exendin-4/chymostatin was added dropwise for SNEDDS. Short term physical stability test was performed prior to the release, lipolysis and permeability studies.

Results:

SNEDDS containing ethyl oleate Cremophor EL® Labrasol® propylene glycole (1542.521.25 21.25) were selected for in vitro release and intestinal permeability studies for suitable parameters and physical stability test results. SNEDDS were obtained which yielded Grade B nanoemulsions having droplet size below 25 nm. In vitro release studies showed that 73.79% of the peptide was released for 2 h at pH 6.8. Both exendin-4 and exendin-4/chymostatin loaded SNEDDS were non-toxic to Caco-2 cells. Permeability coefficients of both exendin-4 loaded SNEDDS and exendin-4/chymostatin loaded SNEDDS were higher than exendin-4 solution.

Conclusions:

Intestinal permeability of exendin-4 has been improved by SNEDDS formulations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Emulsões / Exenatida / Hipoglicemiantes Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Emulsões / Exenatida / Hipoglicemiantes Idioma: En Ano de publicação: 2020 Tipo de documento: Article